What happens when you take phenytoin with folate?
Phenytoin (Dilantin, Phenytek) is one of the oldest and still most widely used anticonvulsants for focal and generalized tonic-clonic seizures. Its interaction with folate is bidirectional and one of the better-documented drug-nutrient interactions in clinical neurology.
In one direction, phenytoin lowers folate. The drug is a potent inducer of hepatic cytochrome P450 enzymes (notably CYP2C9 and CYP3A4) that accelerate the breakdown of folate. It also appears to interfere with the intestinal hydrolysis and absorption of polyglutamate folates — the form found in most foods. The combined effect of higher clearance and lower absorption is a steady decline in serum, red-cell, and cerebrospinal-fluid folate over weeks to months of therapy. Studies have found that anywhere from a quarter to three-quarters of long-term phenytoin users have subnormal folate.
In the other direction, folate lowers phenytoin. Folate appears to serve as a cofactor in phenytoin metabolism, and supplying it in supplement doses increases the affinity of hepatic enzymes for the drug. When folate-deficient patients are given supplemental folic acid, phenytoin clearance speeds up and serum drug levels can fall, sometimes enough to allow seizures to break through. This is the part most patients and even some clinicians miss — adding what feels like a benign vitamin can compromise seizure control.
Why is this important?
Folate deficiency itself carries real risks. Low folate raises homocysteine (a cardiovascular risk factor), can contribute to macrocytic anemia, may worsen mood and cognitive symptoms, and — most critically — sharply increases the risk of neural tube defects when a pregnancy is conceived. Phenytoin is also independently teratogenic and carries an additional risk of fetal hydantoin syndrome, so women of childbearing potential on phenytoin face a genuine clinical dilemma: they need folate to protect a possible pregnancy, but the way folate is supplemented matters.
From the seizure side, a 25 to 50 percent drop in phenytoin level after starting high-dose folate is enough to push some patients from full control back into breakthrough seizures, which carry their own dangers — falls, accidents, status epilepticus, and loss of driving privileges. Several published case reports describe exactly this sequence: patient stable on phenytoin starts folic acid, level drops, seizures return.
What should you do?
If you are on phenytoin, do not start a high-dose folic acid supplement (1 mg or more) without first telling your neurologist. Routine over-the-counter multivitamins typically supply around 400 mcg of folic acid per day, which is generally low enough to be tolerated, but even there it is worth telling your prescriber so they are aware.
If folate supplementation is clinically warranted — pregnancy planning, documented deficiency, hyperhomocysteinemia — your neurologist will usually want a baseline phenytoin level beforehand and a repeat level two to four weeks after starting or changing the folate dose. Phenytoin's pharmacokinetics are nonlinear (Michaelis-Menten), so small dose adjustments can produce large changes in serum concentration; this is also why phenytoin clearance changes from folate supplementation can be unpredictable.
Women on phenytoin who could become pregnant are usually advised to take folic acid daily (often 4 to 5 mg) starting before conception. This must be done in coordination with the neurologist, with phenytoin levels monitored. Do not simply add the folate yourself and hope for the best — and equally important, do not skip folate out of fear of the interaction. Both errors carry consequences.
Which specific products are affected?
The interaction applies to all phenytoin products (Dilantin, Phenytek, generic phenytoin, fosphenytoin / Cerebyx) and likely to a lesser extent to other enzyme-inducing anticonvulsants like phenobarbital, carbamazepine, and primidone. On the supplement side, it applies to folic acid (the synthetic form), folinic acid (leucovorin / 5-formyltetrahydrofolate), and L-methylfolate (5-MTHF, Deplin) — although the methylfolate form may behave somewhat differently kinetically, it has not been shown to be safe at high doses with phenytoin without monitoring.
Note that B-complex supplements, prenatal vitamins, and many "energy" or "hair, skin, and nails" products contain folic acid. Many fortified breakfast cereals, breads, and pastas in the US deliver 100 to 400 mcg of folic acid per serving — usual dietary fortification has not been shown to destabilize phenytoin, but layered supplementation on top of fortification can.
The bottom line
Phenytoin and folate have a tightly coupled, two-way interaction: the drug depletes the vitamin, and the vitamin (at supplement doses) speeds up clearance of the drug and can lower seizure threshold. Do not start or change a folic acid supplement above multivitamin dose without telling your neurologist, and plan ahead for pregnancy with physician-guided dosing and follow-up phenytoin levels.